ADVENTRX logo
Company Products Clinical Trials Partners Investors Resources Contact
Company

MISSION & STRATEGY

STRATEGY

CLINICAL & REGULATORY STRATEGY

COMMERCIALIZATION

HISTORY

TEAM

ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. We seek to improve the performance and safety of existing treatments by addressing significant problems, such as drug metabolism and bioavailability, excessive toxicity and treatment resistance. We hold certain exclusive rights to new therapies for cancer and infectious diseases, including a lead compound, ANX-510 (CoFactor), which is designed to improve the performance and safety of 5-fluorouracil, a widely used chemotherapy. Coupled with these products is an experienced management team with significant product development, clinical, regulatory, finance, and business management expertise.

COMPANY | PRODUCTS | CLINICAL TRIALS | PARTNERS | INVESTORS | RESOURCES | CONTACT
HOME | CAREERS | SEARCH | SITE MAP | HELP | LEGAL
© Copyright 2008 ADVENTRX Pharmaceuticals

Search Careers Back to homepage